首页 | 本学科首页   官方微博 | 高级检索  
检索        

VP与CAP方案治疗晚期非小细胞肺癌65例近期疗效分析
引用本文:房晓萍,赵华,田萍,阚瑛,本巴吉,韩军.VP与CAP方案治疗晚期非小细胞肺癌65例近期疗效分析[J].青海医学院学报,2004,25(2):123-125.
作者姓名:房晓萍  赵华  田萍  阚瑛  本巴吉  韩军
作者单位:青海省人民医院肿瘤内科
摘    要:目的 比较VP与CAP方案治疗晚期非小细胞肺癌的近期疗效。方法 分别采用VP与CAP方案联合化疗 ,治疗晚期非小细胞肺癌 6 5例。结果 VP组 33例 ,有效率 (CR PR)4 2 .4 % ,CAP组 32例 ,有效率 (CR PR) 34.4 %。结论 含铂类药物联合化疗治疗非小细胞肺癌 ,VP方案优于CAP方案

关 键 词:非小细胞肺癌  联合化疗  顺氯氨铂
修稿时间:2003年12月15

ANALYSIS OF THE LATE THERAPEUTIC EFFECT OF VP AND CAP REGIMEN IN THE TREATMENT OF TERMINAL NSCLC OF 65 CASES
Fang Xiaoping Zhao Hua Tian Ping,et al..ANALYSIS OF THE LATE THERAPEUTIC EFFECT OF VP AND CAP REGIMEN IN THE TREATMENT OF TERMINAL NSCLC OF 65 CASES[J].Journal of Qinghai Medical College,2004,25(2):123-125.
Authors:Fang Xiaoping Zhao Hua Tian Ping  
Abstract:Objective To compare the late therapeutic effects of VP and CAP regimen on the treatment of terminal non-small cell lung cancer(NSCLC).Methods Used the combined regimen of VP and CAP to treat 65 cases of terminal NSCLC.Results The response rates (CR PR) for the group of VP regimen (33cases) and the group of CAP regimen (32 cases) were 42.4% and 34.4% respectively. Conclusion While using the drugs which contain platinum to treat terminal NSCLC, the VP regimen superior to the CAP regimen.
Keywords:NSCLC  Combined Chemotherapy  Ciplatin
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号